News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Johnson David Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Bought 13,500 shares
@ $8.2713, valued at
$111.7k
Bought 6,566 shares
@ $8.6068, valued at
$56.5k
|
|
| 06/16/2023 |
4
| Johnson David Michael (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 19,059 shares
@ $0 |
|
| 06/09/2023 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 16,000 options to buy
@ $12.83, valued at
$205.3k
|
|
| 01/09/2023 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Bought 300 shares
@ $10, valued at
$3k
Bought 96 shares
@ $10, valued at
$960
Bought 700 shares
@ $10.5, valued at
$7.4k
Bought 904 shares
@ $10.51, valued at
$9.5k
|
|
| 12/30/2022 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Bought 2,000 shares
@ $9.75, valued at
$19.5k
Bought 2,000 shares
@ $9.75, valued at
$19.5k
|
|
| 12/15/2022 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Bought 5,000 shares
@ $12.37, valued at
$61.9k
Bought 5,000 shares
@ $12.37, valued at
$61.9k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2021 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Converted 139,672 shares
@ $0
Converted 139,672 convertible preferred
@ $0 |
|
| 10/29/2021 |
4
| Johnson David Michael (Director) has filed a Form 4 on Aura Biosciences, Inc.|
Txns:
| Granted 24,000 options to buy
@ $14, valued at
$336k
|
|
| 10/04/2021 |
4
| Johnson David Michael (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 4,892 shares
@ $65.9501, valued at
$322.6k
Sold 7,904 shares
@ $66.579, valued at
$526.2k
Sold 100 shares
@ $67.2, valued at
$6.7k
|
|
| 06/08/2021 |
4
| Johnson David Michael (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 15,000 options to buy
@ $52.25, valued at
$783.8k
|
|
| 04/05/2021 |
4
| Johnson David Michael (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Sold 12,897 shares
@ $43.5001, valued at
$561k
|
|
| 12/03/2020 |
4
| Johnson David Michael (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Bought 4,000 shares
@ $18, valued at
$72k
Sold 1,600 shares
@ $49.8, valued at
$79.7k
Sold 3,868 shares
@ $50.82, valued at
$196.6k
Sold 4,603 shares
@ $51.61, valued at
$237.6k
Sold 2,825 shares
@ $52.72, valued at
$148.9k
|
|
| 04/09/2020 |
4
| Johnson David Michael (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 51,587 shares
@ $0 |
|
|
|